PAR 0.00% 23.5¢ paradigm biopharmaceuticals limited..

Ann: 2021 Annual Report and Appendix 4E, page-79

  1. 85 Posts.
    lightbulb Created with Sketch. 21

    Thanks again for your input. Much appreciated.
    Thanks again Mozz as usual! Are you saying that the slower uptake of iPPS in humans is of benefit due to the fact that therefore it is also likely to stay circulating in the body for longer and that subcut takes longer to be excreted by the kidneys? Just interested to see why they have made these decisions. Really probably only playing in the margins here but I suppose everything counts!

    In other news. Loving the green today. Not sure why, 'another' insider leak perhaps? Just speculating of course
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.000(0.00%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 23.0¢ $133.5K 564.6K

Buyers (Bids)

No. Vol. Price($)
3 108916 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 58538 2
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
23.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
24.0¢ 24.0¢ 23.5¢ 80791
Last updated 15.54pm 17/06/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.